title: The pathogenesis of pulmonary fibrosis: a moving target.
abstract: Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is characterised by excessive matrix formation leading to destruction of the normal lung architecture and finally death. Despite an exponential increase in our understanding of potentially important mediators and mechanisms, the delineation of primary pathways has proven to be elusive. In this review susceptibility and injurious agents, such as viruses and gastro-oesophageal reflux, and their probable role in initiating disease will be discussed. Further topics that are elaborated are candidate ancillary pathways, including immune mechanisms, oxidative and endoplasmic reticulum stress, activation of the coagulation cascade and the potential role of stem cells. This review will try to provide the reader with an integrated view on the current knowledge and attempts to provide a road map for future research. It is important to explore robust models of overall pathogenesis, reconciling a large number of clinical and scientific observations. We believe that the integration of current data into a "big picture" overview of fibrogenesis is essential for the development of effective antifibrotic strategies. The latter will probably consist of a combination of agents targeting a number of key pathways.
authors.affiliation: Laboratory of Pneumology, Dept of Respiratory Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. wim.wuyts@uzleuven.be
authors.forename: Wim A
authors.initials: WA
authors.lastname: Wuyts
authors.forename: Carlo
authors.initials: C
authors.lastname: Agostini
authors.forename: Katerina M
authors.initials: KM
authors.lastname: Antoniou
authors.forename: Demosthenes
authors.initials: D
authors.lastname: Bouros
authors.forename: Rachel C
authors.initials: RC
authors.lastname: Chambers
authors.forename: Vincent
authors.initials: V
authors.lastname: Cottin
authors.forename: Jim J
authors.initials: JJ
authors.lastname: Egan
authors.forename: Bart N
authors.initials: BN
authors.lastname: Lambrecht
authors.forename: Rik
authors.initials: R
authors.lastname: Lories
authors.forename: Helen
authors.initials: H
authors.lastname: Parfrey
authors.forename: Antje
authors.initials: A
authors.lastname: Prasse
authors.forename: Carlos
authors.initials: C
authors.lastname: Robalo-Cordeiro
authors.forename: Eric
authors.initials: E
authors.lastname: Verbeken
authors.forename: Johny A
authors.initials: JA
authors.lastname: Verschakelen
authors.forename: Athol U
authors.initials: AU
authors.lastname: Wells
authors.forename: Geert M
authors.initials: GM
authors.lastname: Verleden
mesh_terms: D000818:Animals; D001777:Blood Coagulation; D018450:Disease Progression; D059865:Endoplasmic Reticulum Stress; D004847:Epithelial Cells / Q000166:cytology; D005764:Gastroesophageal Reflux / Q000503:physiopathology; D020022:Genetic Predisposition to Disease; D006801:Humans; D051379:Mice; D009154:Mutation; D018384:Oxidative Stress; D011650:Pulmonary Alveoli / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology*; D013234:Stem Cells / Q000166:cytology
keywords: Coagulation; fibrosis; immunology; pathogenesis; pulmonary fibrosis